Page last updated: 2024-10-25

deferoxamine and Leukemia, Myelomonocytic, Acute

deferoxamine has been researched along with Leukemia, Myelomonocytic, Acute in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Leukemia, Myelomonocytic, Acute: A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weiss, G1
Graziadel, I1
Urbanek, M1
Grünewald, K1
Vogel, W1

Other Studies

1 other study available for deferoxamine and Leukemia, Myelomonocytic, Acute

ArticleYear
Divergent effects of alpha 1-antitrypsin on the regulation of iron metabolism in human erythroleukaemic (K562) and myelomonocytic (THP-1) cells.
    The Biochemical journal, 1996, Nov-01, Volume: 319 ( Pt 3)

    Topics: alpha 1-Antitrypsin; Cell Line; Deferoxamine; Ferritins; Humans; Iron; Iron-Regulatory Proteins; Iro

1996